Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSanegre, Sabina
dc.contributor.authorEritja, Núria
dc.contributor.authorde Andrea, Carlos
dc.contributor.authorDiaz-Martin, Juan
dc.contributor.authorDiaz-Lagares, Ángel
dc.contributor.authorJácome, María Amalia
dc.contributor.authorRamon y Cajal Agüeras, Santiago
dc.date.accessioned2022-03-24T14:03:20Z
dc.date.available2022-03-24T14:03:20Z
dc.date.issued2021-06
dc.identifier.citationSanegre S, Eritja N, de Andrea C, Diaz-Martin J, Diaz-Lagares Á, Jácome MA, et al. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. Front Cell Dev Biol. 2021 Jun;9:670185.
dc.identifier.issn2296-634X
dc.identifier.urihttps://hdl.handle.net/11351/7262
dc.descriptionPerfils epigenètics; Matriu extracel·lular; Cèl·lules immunes
dc.description.sponsorshipThis research was supported by grants from the ISCIII and ERDF (PI17/01558 and PI20/01107), by the CIBERONC (contracts CB16/12/00484, CB16/12/0328, CB16/12/00363, CB16/12/00364, CB16/12/00481, and CB16/12/00231) and Grupos Coordinados Estables from the Asociación Española Contra el Cáncer (AECC). ÁD-L was funded by a contract “Juan Rodés” from the ISCIII (JR17/00016). The funders had no involvement in the research process nor in the preparation and submission of the article.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Cell and Developmental Biology;9
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectÚter - Tumors
dc.subjectMúsculs - Càncer
dc.subjectMarcadors tumorals
dc.subject.meshLeiomyosarcoma
dc.subject.meshUterine Neoplasms
dc.subject.meshBiomarkers, Tumor
dc.titleCharacterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fcell.2021.670185
dc.subject.decsleiomiosarcoma
dc.subject.decsneoplasias uterinas
dc.subject.decsmarcadores tumorales
dc.relation.publishversionhttps://doi.org/10.3389/fcell.2021.670185
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Sanegre S] Cancer CIBER (CIBERONC), Madrid, Spain. Department of Pathology, School of Medical, University of Valencia-INCLIVA, Valencia, Spain. [Eritja N] Cancer CIBER (CIBERONC), Madrid, Spain. Institut de Recerca Biomèdica de LLeida (IRBLLEIDA), Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Department of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, University of Lleida - University of Barcelona, Barcelona, Spain. [de Andrea C] Cancer CIBER (CIBERONC), Madrid, Spain. Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain. [Diaz-Martin J] Cancer CIBER (CIBERONC), Madrid, Spain. Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain. [Diaz-Lagares Á] Cancer CIBER (CIBERONC), Madrid, Spain. Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain. [Jácome MA] Department of Mathematics, MODES Group, CITIC, Faculty of Science, Universidade da Coruña, A Coruña, Spain. [Ramon Y Cajal S] Cancer CIBER (CIBERONC), Madrid, Spain. Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34150764
dc.identifier.wos000662202000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple